Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 6, 2014, Pages E469-E484

  Bodine, Sue C ^a,b   Baehr, Leslie M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Northern California Veterans Affairs Health Systems ^*  (United States)

Author keywords

Atrogenes; Muscle atrophy F box; Muscle RING finger 1; Muscle sparing; Protein quality control; Ubiquitin proteasome system

Indexed keywords

ATROGIN 1; CCAAT ENHANCER BINDING PROTEIN BETA; F BOX PROTEIN; FORKHEAD TRANSCRIPTION FACTOR 04; INITIATION FACTOR 3; KRUPPEL LIKE FACTOR 15; LIGASE; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; MUSCLE UBIQUITIN LIGASE OF SCF COMPLEX IN ATROPHY 1; MYOD PROTEIN; MYOSTATIN; PROTEASOME; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRIPARTITE MOTIF PROTEIN 32; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG; FBXO32 PROTEIN, HUMAN; FBXO32 PROTEIN, MOUSE; TRIM63 PROTEIN, HUMAN; TRIM63 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

CELL FUNCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; GENE DELETION; GENE EXPRESSION; HUMAN; INFLAMMATION; MALNUTRITION; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE MASS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; SKELETAL MUSCLE ATROPHY; TRANSCRIPTION REGULATION; UBIQUITINATION; ANIMAL; ATROGENES; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MUSCLE ATROPHY F-BOX; MUSCLE SPARING; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PROTEIN QUALITY CONTROL; UBIQUITIN PROTEASOME SYSTEM;

ATROGENES; MUSCLE ATROPHY F-BOX; MUSCLE RING FINGER 1; MUSCLE SPARING; PROTEIN QUALITY CONTROL; UBIQUITIN PROTEASOME SYSTEM;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; ORGAN SIZE; PROTEASOME ENDOPEPTIDASE COMPLEX; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN-PROTEIN LIGASES;

EID: 84907727935     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00204.2014     Document Type: Review

References (197)

1. Adams V, Mangner N, Gasch A, Krohne C, Gielen S, Hirner S, Thierse HJ, Witt CC, Linke A, Schuler G, Labeit S. Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice. J Mol Biol 384: 48-59, 2008.
2. Allen DL, Bandstra ER, Harrison BC, Thorng S, Stodieck LS, Kostenuik P., Morony S, Lacey DL, Hammond TG, Leinwand LL, Argraves WS, Bateman TA, Barth JL. Effects of spaceflight on murine skeletal muscle gene expression. J Appl Physiol 106: 582-595, 2009.
3. Allen DL, Cleary AS, Lindsay SF, Loh AS, Reed JM. Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice. J Appl Physiol 109: 692-701, 2010.
4. Almon RR, DuBois DC, Yao Z, Hoffman EP. Ghimbovschi S, Jusko WJ. Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. Physiol Genomics 30: 282-299, 2007.
5. Altun M, Besche HC, Overkleeft HS, P.ccirillo R, Edelmann MJ, Kessler BM, Goldberg AL, Ulfhake B. Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway. J Biol Chem 285: 39597-39608, 2010.
6. Asp ML, Tian M, Wendel AA, Belury MA. Evidence for the contribution of insulin resistance to the development of cachexia in tumorbearing mice. Int J Cancer 126: 756-763, 2010.
7. Baehr LM, Furlow JD, Bodine SC. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J Physiol 589: 4759-4776, 2011.
8. Baehr LM, Tunzi M, Bodine SC. Muscle hypertrophy is associated with increases in proteasome activity that is independent of MuRF1 and MAFbx expression. Front Physiol 5: 69, 2014.
9. Bailey AN, Hocker AD, Vermillion BR, Smolkowski K, Shah SN, Jewett BA, Dreyer HC. MAFbx, MuRF1, and the stress-activated protein kinases are upregulated in muscle cells during total knee arthroplasty. Am J Physiol Regul Integr Comp Physiol 303: R376-R386, 2012.
10. Balasubramaniam A, Joshi R, Su C, Friend LA, Sheriff S, Kagan RJ, James JH. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx. Am J Physiol Regul Integr Comp Physiol 296: R893-R901, 2009.
11. Baptista IL, Leal ML, Artioli GG, Aoki MS, Fiamoncini J, Turri AO, Curi R, Miyabara EH, Moriscot AS. Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligases. Muscle Nerve 41: 800-808, 2010.
12. Bar-Shai M, Carmeli E, Ljubuncic P. Reznick AZ. Exercise and immobilization in aging animals: the involvement of oxidative stress and NF-kappaB activation. Free Radic Biol Med 44: 202-214, 2008.
13. Batt J, Bain J, Goncalves J, Michalski B, P.ant P. Fahnestock M, Woodgett J. Differential gene expression profiling of short and long term denervated muscle. FASEB J 20: 115-117, 2006.
14. Batt J, Ahmed SS, Correa J, Bain A, Granton J. Skeletal Muscle Dysfunction in Idiopathic P.lmonary Arterial Hypertension. Am J Respir Cell Mol Biol 50: 74-86, 2014.
15. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, P.ueymirou WT, P.naro FJ, Na E, Dharmarajan K, P.n ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001.
16. Bollinger LM, Witczak CA, Houmard JA, Brault JJ. SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-bindingdependent manner. Am J Physiol Cell Physiol 307: C278-C287, 2014.
17. Bonaldo P. Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 6: 25-39, 2013.
18. Bongers KS, Fox DK, Ebert SM, Kunkel SD, Dyle MC, Bullard SA, Dierdorff JM, Adams CM. Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4. Am J Physiol Endocrinol Metab 305: E907-E915, 2013.
19. Bricceno KV, Sampognaro P., Van Meerbeke JP. Sumner CJ, Fischbeck KH, Burnett BG. Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy mice. Hum Mol Genet 21: 4448-4459, 2012.
20. Cai D, Frantz JD, Tawa NE Jr, Melendez P., Oh BC, Lidov HG, Hasselgren P., Frontera WR, Lee J, Glass DJ, Shoelson SE. IKK-beta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298, 2004.
21. Cardozo T, P.gano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 5: 739-751, 2004.
22. Caron AZ, Haroun S, Leblanc E, Trensz F, Guindi C, Amrani A, Grenier G. The proteasome inhibitor MG132 reduces immobilizationinduced skeletal muscle atrophy in mice. BMC Musculoskelet Disord 12: 185, 2011.
23. Carvalho RF, Castan EP. Coelho CA, Lopes FS, Almeida FL, Michelin A, de Souza RW, Araújo JP.Jr, Cicogna AC, Dal P.i-Silva M. Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy. J Mol Histol 41: 81-87, 2010.
24. Centner T, Yano J, Kimura E, McElhinny AS, P.lin K, Witt CC, Bang ML, Trombitas K, Granzier H, Gregorio CC, Sorimachi H, Labeit S. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol 306: 717-726, 2001.
25. Chen YW, Gregory CM, Scarborough MT, Shi R, Walter GA, Vandenborne K. Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. Physiol Genomics 31: 510-520, 2007.
26. Chen Y, Cao L, Ye J, Zhu D. Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin. Biochem Biophys Res Commun 388: 112-116, 2009.
27. Cho JE, Fournier M, Da X, Lewis MI. Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration. J Appl Physiol 108: 137-145, 2010.
28. Christensen DE, Klevit RE. Dynamic interactions of proteins in complex networks: identifying the complete set of interacting E2s for functional investigation of E3-dependent protein ubiquitination. FEBS J 276: 5381-5389, 2009.
29. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, P.tterson C, Latres E, Glass DJ. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasonetreated skeletal muscle. Cell Metab 6: 376-385, 2007.
30. Clavel S, Coldefy AS, Kurkdjian E, Salles J, Margaritis I, Derijard B. Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are upregulated in aged rat Tibialis Anterior muscle. Mech Ageing Dev 127: 794-801, 2006.
31. Cohen S, Brault JJ, Gygi SP. Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185: 1083-1095, 2009.
32. Cohen S, Zhai B, Gygi SP. Goldberg AL. Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy. J Cell Biol 198: 575-589, 2012.
33. Costelli P. Muscaritoli M, Bossola M, P.nna F, Reffo P. Bonetto A, Busquets S, Bonelli G, Lopez-Soriano FJ, Doglietto GB, Argilés JM, Baccino FM, Rossi Fanelli F. IGF-1 is downregulated in experimental cancer cachexia. Am J Physiol Regul Integr Comp Physiol 291: R674-R683, 2006.
34. Davis TA, Fiorotto ML. Regulation of muscle growth in neonates. Curr Opin Clin Nutr Metab Care 12: 78-85, 2009.
35. de Boer MD, Selby A, Atherton P. Smith K, Seynnes OR, Maganaris CN, Maffulli N, Movin T, Narici MV, Rennie MJ. The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol 585: 241-251, 2007.
36. Dehoux M, Van Beneden R, P.sko N, Lause P. Verniers J, Underwood L, Ketelslegers JM, Thissen JP. Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes. Endocrinology 145: 4806-4812, 2004.
37. Dehoux MJ, van Beneden RP. Fernández-Celemín L, Lause P., Thissen JP. Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LP. injection. FEBS Lett 544: 214-217, 2003.
38. Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399-434, 2009.
39. de Theije CC, Langen RC, Lamers WH, Schols AM, Köhler SE. Distinct responses of protein turnover regulatory pathways in hypoxiaand semistarvation-induced muscle atrophy. Am J Physiol Lung Cell Mol Physiol 305: L82-L91, 2013.
40. Doucet M, Russell AP. Leger B, Debigare R, Joanisse DR, Caron MA, LeBlanc P. Maltais F. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176: 261-269, 2007.
41. Doyle A, Zhang G, Abdel Fattah EA, Eissa NT, Li YP. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J 25: 99-110, 2011.
42. Ebert SM, Dyle MC, Kunkel SD, Bullard SA, Bongers KS, Fox DK, Dierdorff JM, Foster ED, Adams CM. Stress-induced skeletal muscle Gadd45a expression reprograms myonuclei and causes muscle atrophy. J Biol Chem 287: 27290-27301, 2012.
43. Edström E, Altun M, Hägglund M, Ulfhake B. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci 61: 663-674, 2006.
44. Files DC, D’Alessio FR, Johnston LF, Kesari P. Aggarwal NR, Garibaldi BT, Mock JR, Simmers JL, DeGorordo A, Murdoch J, Willis MS, P.tterson C, Tankersley CG, Messi ML, Liu C, Delbono O, Furlow JD, Bodine SC, Cohn RD, King LS, Crow MT. A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. Am J Respir Crit Care Med 185: 825-834, 2012.
45. Fox DK, Ebert SM, Bongers KS, Dyle MC, Bullard SA, Dierdorff JM, Kunkel SD, Adams CM. p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization. Am J Physiol Endocrinol Metab 307: E245-E261, 2014.
46. Frost RA, Nystrom GJ, Jefferson LS, Lang CH. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. Am J Physiol Endocrinol Metab 292: E501-E512, 2007.
47. Furlow JD, Watson ML, Waddell DS, Neff ES, Baehr LM, Ross AP. Bodine SC. Altered gene expression patterns in muscle ring finger 1 null mice during denervationand dexamethasone-induced muscle atrophy. Physiol Genomics 45: 1168-1185, 2013.
48. Furuyama T, Kitayama K, Yamashita H, Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of P.K4 gene expression in skeletal muscle during energy deprivation. Biochem J 375: 365-371, 2003.
49. Gaugler M, Brown A, Merrell E, DiSanto-Rose M, Rathmacher JA, Reynolds TH. P.B signaling and atrogene expression in skeletal muscle of aged mice. J Appl Physiol 111: 192-199, 2011.
50. Goldberg AL. Protein turnover in skeletal muscle. II. Effects of denervation and cortisone on protein catabolism in skeletal muscle. J Biol Chem 244: 3223-3229, 1969.
51. Gomes AV, Waddell DS, Siu R, Stein M, Dewey S, Furlow JD, Bodine SC. Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation. FASEB J 26: 2986-2999, 2012.
52. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. P.oc Natl Acad Sci USA 98: 14440-14445, 2001.
53. Gonçalves DA, Lira EC, Baviera AM, Cao P. Zanon NM, Arany Z, Bedard N, Tanksale P. Wing SS, Lecker SH, Kettelhut IC, Navegantes LC. Mechanisms involved in 3=,5=-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle. Endocrinology 150: 5395-5404, 2009.
54. Gonçalves DA, Silveira WA, Lira EC, Graça FA, P.ula-Gomes S, Zanon NM, Kettelhut IC, Navegantes LC. Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt. Am J Physiol Endocrinol Metab 302: E123-E133, 2012.
55. Goodman CA, McNally RM, Hoffmann FM, Hornberger TA. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo. Mol Endocrinol 27: 1946-1957, 2013.
56. Granado M, P.iego T, Martín AI, Villanúa MA, López-Calderón A. Ghrelin receptor agonist GHRP.2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. Am J Physiol Endocrinol Metab 289: E1007-E1014, 2005.
57. Gustafsson T, Osterlund T, Flanagan JN, von Waldén F, Trappe TA, Linnehan RM, Tesch P.. Effects of 3 days unloading on molecular regulators of muscle size in humans. J Appl Physiol 109: 721-727, 2010.
58. Hanai J, Cao P. Tanksale P. Imamura S, Koshimizu E, Zhao J, Kishi S, Yamashita M, P.illips P., Sukhatme VP. Lecker SH. The musclespecific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. J Clin Invest 117: 3940-3951, 2007.
59. Hanson AM, Harrison BC, Young MH, Stodieck LS, Ferguson VL. Longitudinal characterization of functional, morphologic, and biochemical adaptations in mouse skeletal muscle with hindlimb suspension. Muscle Nerve 48: 393-402, 2013.
60. Herrera NM Jr, Zimmerman AN, Dykstra DD, Thompson LV. Clenbuterol in the prevention of muscle atrophy: a study of hindlimbunweighted rats. Arch P.ys Med Rehabil 82: 930-934, 2001.
61. Hirner S, Krohne C, Schuster A, Hoffmann S, Witt S, Erber R, Sticht C, Gasch A, Labeit S, Labeit D. MuRF1-dependent regulation of systemic carbohydrate metabolism as revealed from transgenic mouse studies. J Mol Biol 379: 666-677, 2008.
62. Hu Z, Wang H, Lee IH, Du J, Mitch WE. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J Clin Invest 119: 3059-3069, 2009.
63. Hwee DT, Baehr LM, P.ilp A, Baar K, Bodine SC. Maintenance of muscle mass and load-induced growth in Muscle RING Finger 1 null mice with age. Aging Cell 13: 92-101, 2014.
64. Hwee DT, Gomes AV, Bodine SC. Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment. Am J Physiol Endocrinol Metab 301: E967-E977, 2011.
65. Jackman RW, Cornwell EW, Wu CL, Kandarian SC. Nuclear factorB signalling and transcriptional regulation in skeletal muscle atrophy. Exp Physiol 98: 19-24, 2013.
66. Jackman RW, Wu CL, Kandarian SC. The ChIP.seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy. P.oS One 7: e51478, 2012.
67. Jagoe RT, Lecker SH, Gomes M, Goldberg AL. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J 16: 1697-1712, 2002.
68. Jin J, Cardozo T, Lovering RC, Elledge SJ, P.gano M, Harper JW. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev 18: 2573-2580, 2004.
69. Jogo M, Shiraishi S, Tamura TA. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase. FEBS Lett 583: 2715-2719, 2009.
70. Jones SW, Hill RJ, Krasney P., O’Conner B, P.irce N, Greenhaff P.. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 18: 1025-1027, 2004.
71. Judge AR, Koncarevic A, Hunter RB, Liou HC, Jackman RW, Kandarian SC. A role for I B, but not c-Rel, in skeletal muscle atrophy. Am J Physiol Cell Physiol 292: C372-C382, 2007.
72. Kedar V, McDonough H, Arya R, Li HH, Rockman HA, P.tterson C. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. P.oc Natl Acad Sci USA 101: 18135-18140, 2004.
73. Kim HT, Kim KP. Lledias F, Kisselev AF, Scaglione KM, Skowyra D, Gygi SP. Goldberg AL. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 282: 17375-17386, 2007.
74. Kim J, Won KJ, Lee HM, Hwang BY, Bae YM, Choi WS, Song H, Lim KW, Lee CK, Kim B. p38 MAP. P.rticipates in Muscle-Specific RING Finger 1-Mediated Atrophy in Cast-Immobilized Rat Gastrocnemius Muscle. Korean J Physiol P.armacol 13: 491-496, 2009.
75. Kline WO, P.naro FJ, Yang H, Bodine SC. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J Appl Physiol 102: 740-747, 2007.
76. Koncarevic A, Jackman RW, Kandarian SC. The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension. FASEB J 21: 427-437, 2007.
77. Koyama S, Hata S, Witt CC, Ono Y, Lerche S, Ojima K, Chiba T, Doi N, Kitamura F, Tanaka K, Abe K, Witt SH, Rybin V, Gasch A, Franz T, Labeit S, Sorimachi H. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. J Mol Biol 376: 1224-1236, 2008.
78. Kravtsova-Ivantsiv Y, Ciechanover A. Non-canonical ubiquitin-based signals for proteasomal degradation. J Cell Sci 125: 539-548, 2012.
79. Krawiec BJ, Frost RA, Vary TC, Jefferson LS, Lang CH. Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis. Am J Physiol Endocrinol Metab 289: E969-E980, 2005.
80. Kudryashova E, Kudryashov D, Kramerova I, Spencer MJ. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. J Mol Biol 354: 413-424, 2005.
81. Kudryashova E, Wu J, Havton LA, Spencer MJ. Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic component. Hum Mol Genet 18: 1353-1367, 2009.
82. Kumar A, Bhatnagar S, P.ul P.. TWEAK and TRAF6 regulate skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care 15: 233-239, 2012.
83. Labeit S, Kohl CH, Witt CC, Labeit D, Jung J, Granzier H. Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice. J Biomed Biotechnol 2010: 693-741, 2010.
84. Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP. Batonnet-P.chon S, Tintignac LA, Segura CT, Leibovitch SA. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J 27: 1266-1276, 2008.
85. Lamothe B, Besse A, Campos AD, Webster WK, Wu H, Darnay BG. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J Biol Chem 282: 4102-4112, 2007.
86. Lang CH, Huber D, Frost RA. Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I. Am J Physiol Regul Integr Comp Physiol 292: R328-R336, 2007.
87. Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P. Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B, Gunnarsson LG, Hughes SM, Marchand S, Sejersen T, Richard I, Edström L, Ehler E, Udd B, Gautel M. The kinase domain of titin controls muscle gene expression and protein turnover. Science 308: 1599-1603, 2005.
88. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, P.ice SR, Mitch WE, Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51, 2004.
89. Lee HK, Rocnik E, Fu Q, Kwon B, Zeng L, Walsh K, Querfurth H. Foxo/atrogin induction in human and experimental myositis. Neurobiol Dis 46: 463-475, 2012.
90. Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 15: 1537-1545, 2004.
91. Léger B, Senese R, Al-Khodairy AW, Dériaz O, Gobelet C, Giacobino JP. Russell AP. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP. are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve 40: 69-78, 2009.
92. Léger B, Vergani L, Sorarù G, Hespel P. Derave W, Gobelet C, D’Ascenzio C, Angelini C, Russell AP. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20: 583-585, 2006.
93. Lemire BB, Debigaré R, Dubé A, Thériault ME, Côté CH, Maltais F. MAP. signaling in the quadriceps of patients with chronic obstructive pulmonary disease. J Appl Physiol 113: 159-166, 2012.
94. Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P. Zhu J, Sachdeva R, Sonnad S, Kaiser LR, Rubinstein NA, P.wers SK, Shrager JB. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 358: 1327-1335, 2008.
95. Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, P.tterson C. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114: 1058-1071, 2004.
96. Li W, Claypool MD, Friera AM, McLaughlin J, Baltgalvis KA, Smith IJ, Kinoshita T, White K, Lang W, Godinez G, P.yan DG, Kinsella TM. Noninvasive imaging of in vivo MuRF1 expression during muscle atrophy. P.oS One 9: e94032, 2014.
97. Li YP. Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. TNF-acts via p38 MAP. to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19: 362-370, 2005.
98. Lokireddy S, McFarlane C, Ge X, Zhang H, Sze SK, Sharma M, Kambadur R. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. Mol Endocrinol 25: 1936-1949, 2011.
99. Lokireddy S, Wijesoma IW, Bonala S, Wei M, Sze SK, McFarlane C, Kambadur R, Sharma M. Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem J 446: 23-36, 2012.
100. Lokireddy S, Wijesoma IW, Sze SK, McFarlane C, Kambadur R, Sharma M. Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. Am J Physiol Cell Physiol 303: C512-C529, 2012.
101. Lomonosova YN, Shenkman BS, Nemirovskaya TL. Attenuation of unloading-induced rat soleus atrophy with the heat-shock protein inducer 17-(allylamino)-17-demethoxygeldanamycin. FASEB J 26: 4295-4301, 2012.
102. Louis E, Raue U, Yang Y, Jemiolo B, Trappe S. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol 103: 1744-1751, 2007.
103. Matern P., Li N, Hwee DT, Chiamvimonvat N, Bodine SC. Development of congestive heart failure in mice with a null deletion of MAFbx (Abstract). FASEB J 24: 1036.17, 2010.
104. Mayans O, Labeit S. MuRFs specialized members of the TRIM/RBCC family with roles in the regulation of the trophic state of muscle and its metabolism. In: TRIM/RBCC P.oteins, edited by Meroni G. New York: Springer, 2012, p. 119-129.
105. McElhinny AS, Kakinuma K, Sorimachi H, Labeit S, Gregorio CC. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J Cell Biol 157: 125-136, 2002.
106. McElhinny AS, P.rry CN, Witt CC, Labeit S, Gregorio CC. Musclespecific RING finger-2 (MURF-2) is important for microtubule, intermediate filament and sarcomeric M-line maintenance in striated muscle development. J Cell Sci 117: 3175-3188, 2004.
107. Mendias CL, Gumucio JP. Davis ME, Bromley CW, Davis CS, Brooks SV. Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis. Muscle Nerve 45: 55-59, 2012.
108. Metzger MB, Hristova VA, Weissman AM. HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci 125: 531-537, 2012.
109. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335: 1897-1905, 1996.
110. Mitch WE, Medina R, Grieber S, May RC, England BK, P.ice SR, Bailey JL, Goldberg AL. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 93: 2127-2133, 1994.
111. Miyazaki M, Esser KA. Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals. J Appl Physiol 106: 1367-1373, 2009.
112. Moresi V, Williams AH, Meadows E, Flynn JM, P.tthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, Bassel-Duby R, Olson EN. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143: 35-45, 2010.
113. Mourkioti F, Kratsios P. Luedde T, Song YH, Delafontaine P. Adami R, P.rente V, Bottinelli R, P.sparakis M, Rosenthal N. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest 116: 2945-2954, 2006.
114. Moylan JS, Smith JD, Chambers MA, McLoughlin TJ, Reid MB. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling. Am J Physiol Cell Physiol 295: C986-C993, 2008.
115. Mrosek M, Meier S, Ucurum-Fotiadis Z, von Castelmur E, Hedbom E, Lustig A, Grzesiek S, Labeit D, Labeit S, Mayans O. Structural analysis of B-Box 2 from MuRF1: identification of a novel self-association pattern in a RING-like fold. Biochemistry 47: 10722-10730, 2008.
116. Nagpal P. P.ant P., Correa J, Bain A, Takeda M, Kawabe H, Rotin D, Bain JR, Batt JA. The ubiquitin ligase Nedd4-1 participates in denervation-induced skeletal muscle atrophy in mice. P.oS One 7: e46427, 2012.
117. Napolitano LM, Jaffray EG, Hay RT, Meroni G. Functional interactions between ubiquitin E2 enzymes and TRIM proteins. Biochem J 434: 309-319, 2011.
118. Navon A, Ciechanover A. The 26 S proteasome: from basic mechanisms to drug targeting. J Biol Chem 284: 33713-33718, 2009.
119. Nicolas N, Marazzi G, Kelley K, Sassoon D. Embryonic deregulation of muscle stress signaling pathways leads to altered postnatal stem cell behavior and a failure in postnatal muscle growth. Dev Biol 281: 171-183, 2005.
120. Nikawa T, Ishidoh K, Hirasaka K, Ishihara I, Ikemoto M, Kano M, Kominami E, Nonaka I, Ogawa T, Adams GR, Baldwin KM, Yasui N, Kishi K, Takeda Si. Skeletal muscle gene expression in space-flown rats. FASEB J 18: 522-524, 2004.
121. Nordquist J, Höglund AS, Norman H, Tang X, Dworkin B, Larsson L. Transcription factors in muscle atrophy caused by blocked neuromuscular transmission and muscle unloading in rats. Mol Med 13: 461-470, 2007.
122. Ochala J, Gustafson AM, Diez ML, Renaud G, Li M, Aare S, Qaisar R, Banduseela VC, Hedström Y, Tang X, Dworkin B, Ford GC, Nair KS, P.rera S, Gautel M, Larsson L. P.eferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms. J Physiol 589: 2007-2026, 2011.
123. Ogawa T, Furochi H, Mameoka M, Hirasaka K, Onishi Y, Suzue N, Oarada M, Akamatsu M, Akima H, Fukunaga T, Kishi K, Yasui N, Ishidoh K, Fukuoka H, Nikawa T. Ubiquitin ligase gene expression in healthy volunteers with 20-day bedrest. Muscle Nerve 34: 463-469, 2006.
124. Okamoto T, Torii S, Machida S. Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles. J Physiol Sci 61: 537-546, 2011.
125. Otis JS, Ashikhmin YI, Brown LA, Guidot DM. Effect of HIV-1related protein expression on cardiac and skeletal muscles from transgenic rats. AIDS Res Ther 5: 8, 2008.
126. Otis JS, Guidot DM. P.ocysteine stimulates expression of key anabolic factors and reduces plantaris atrophy in alcohol-fed rats. Alcohol Clin Exp Res 33: 1450-1459, 2009.
127. Ottenheijm CA, Heunks LM, Li YP. Jin B, Minnaard R, van Hees HW, Dekhuijzen P.. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174: 997-1002, 2006.
128. P.ssmore LA, Barford D. Getting into position: the catalytic mechanisms of protein ubiquitylation. Biochem J 379: 513-525, 2004.
129. P.ul P., Bhatnagar S, Mishra V, Srivastava S, Darnay BG, Choi Y, Kumar A. The E3 ubiquitin ligase TRAF6 intercedes in starvationinduced skeletal muscle atrophy through multiple mechanisms. Mol Cell Biol 32: 1248-1259, 2012.
130. P.ul P., Gupta SK, Bhatnagar S, P.nguluri SK, Darnay BG, Choi Y, Kumar A. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol 191: 1395-1411, 2010.
131. P.nna F, Costamagna D, Fanzani A, Bonelli G, Baccino FM, Costelli P. Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. P.oS One 5: e13604, 2010.
132. P.rera S, Mankoo B, Gautel M. Developmental regulation of MURF E3 ubiquitin ligases in skeletal muscle. J Muscle Res Cell Motil 33: 107-122, 2012.
133. P.rrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 205: 201-210, 2010.
134. P.tersen AM, Magkos F, Atherton P. Selby A, Smith K, Rennie MJ, P.dersen BK, Mittendorfer B. Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle. Am J Physiol Endocrinol Metab 293: E843-E848, 2007.
135. P.troski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6: 9-20, 2005.
136. P.zon V, Iakovenko A, Van Der Ven P., Kelly R, Fatu C, Fürst DO, Karsenti E, Gautel M. Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein. J Cell Sci 115: 4469-4482, 2002.
137. P.ant P., Brooks D, Faughnan M, Bayley T, Bain J, Singer L, Correa J, P.arce D, Binnie M, Batt J. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 42: 461-471, 2010.
138. P.lge C, Heng AE, Jarzaguet M, Ventadour S, Claustre A, Combaret L, Béchet D, Matondo M, Uttenweiler-Joseph S, Monsarrat B, Attaix D, Taillandier D. Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1. FASEB J 25: 3790-3802, 2011.
139. P.rporato P., Filigheddu N, Reano S, Ferrara M, Angelino E, Gnocchi VF, P.odam F, Ronchi G, Fagoonee S, Fornaro M, Chianale F, Baldanzi G, Surico N, Sinigaglia F, P.rroteau I, Smith RG, Sun Y, Geuna S, Graziani A. Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest 123: 611-622, 2013.
140. P.rtbury AL, Ronnebaum SM, Zungu M, P.tterson C, Willis MS. Back to your heart: ubiquitin proteasome system-regulated signal transduction. J Mol Cell Cardiol 52: 526-537, 2012.
141. P.ice SR, Bailey JL, Wang X, Jurkovitz C, England BK, Ding X, P.illips LS, Mitch WE. Muscle wasting in insulinopenic rats results from activation of the ATP.dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 98: 1703-1708, 1996.
142. P.uznak AM, Hong-Brown L, Lantry R, She P. Frost RA, Vary TC, Lang CH. Skeletal and cardiac myopathy in HIV-1 transgenic rats. Am J Physiol Endocrinol Metab 295: E964-E973, 2008.
143. Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. P.oteolytic gene expression differs at rest and after resistance exercise between young and old women. J Gerontol A Biol Sci Med Sci 62: 1407-1412, 2007.
144. Reed SA, Sandesara P., Senf SM, Judge AR. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB J 26: 987-1000, 2012.
145. Rhoads MG, Kandarian SC, P.celli F, Doglietto GB, Bossola M. Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients. Eur J Cancer 46: 191-197, 2010.
146. Rubel C, Schisler J, Hamlett E, DeKroon R, Gautel M, Alzate O, P.tterson C. Diggin’ on u(biquitin): a novel method for the identification of physiological E3 ubiquitin ligase substrates. Cell Biochem Biophys 67: 127-138, 2013.
147. Sacheck JM, Hyatt JP. Raffaello A, Jagoe RT, Roy RR, Edgerton VR, Lecker SH, Goldberg AL. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 21: 140-155, 2007.
148. Salanova M, Schiffl G, Püttmann B, Schoser BG, Blottner D. Molecular biomarkers monitoring human skeletal muscle fibres and microvasculature following long-term bed rest with and without countermeasures. J Anat 212: 306-318, 2008.
149. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, P.card A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004.
150. Sartori R, Milan G, P.tron M, Mammucari C, Blaauw B, Abraham R, Sandri M. Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296: C1248-C1257, 2009.
151. Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E, Stantzou A, Mouisel E, Toniolo L, Ferry A, Stricker S, Goldberg AL, Dupont S, P.ccolo S, Amthor H, Sandri M. BMP.signaling controls muscle mass. Nat Genet 45: 1309-1318, 2013.
152. Sato S, Ogura Y, Kumar A. TWEAK/Fn14 signaling axis mediates skeletal muscle atrophy and metabolic dysfunction. Front Immunol 5: 18, 2014.
153. Schoser BG, Frosk P. Engel AG, Klutzny U, Lochmüller H, Wrogemann K. Commonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H. Ann Neurol 57: 591-595, 2005.
154. Schwartz AL, Ciechanover A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev P.armacol Toxicol 49: 73-96, 2009.
155. Senf SM, Dodd SL, Judge AR. FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70. Am J Physiol Cell Physiol 298: C38-C45, 2010.
156. Senf SM, Dodd SL, McClung JM, Judge AR. Hsp70 overexpression inhibits NFB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J 22: 3836-3845, 2008.
157. Sheriff S, Joshi R, Friend LA, James JH, Balasubramaniam A. Ghrelin receptor agonist, GHRP.2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. P.ptides 30: 1909-1913, 2009.
158. Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, Takeda S, Nakae J, Tagata Y, Nishitani S, Takehana K, Sano M, Fukuda K, Suematsu M, Morimoto C, Tanaka H. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab 13: 170-182, 2011.
159. Siddiqui RA, Hassan S, Harvey KA, Rasool T, Das T, Mukerji P. DeMichele S. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice. Br J Nutr 102: 967-975, 2009.
160. Skaar JR, P.gan JK, P.gano M. Mechanisms and function of substrate recruitment by F-box proteins. Nat Rev Mol Cell Biol 14: 369-381, 2013.
161. Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91: 209-219, 1997.
162. Slimani L, Micol D, Amat J, Delcros G, Meunier B, Taillandier D, P.lge C, Béchet D, Dardevet D, P.card B, Attaix D, Listrat A, Combaret L. The worsening of tibialis anterior muscle atrophy during recovery post-immobilization correlates with enhanced connective tissue area, proteolysis, and apoptosis. Am J Physiol Endocrinol Metab 303: E1335-E1347, 2012.
163. Sneddon AA, Delday MI, Maltin CA. Amelioration of denervationinduced atrophy by clenbuterol is associated with increased P.Cactivity. Am J Physiol Endocrinol Metab 279: E188-E195, 2000.
164. Solomon V, Baracos V, Sarraf P. Goldberg AL. Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. P.oc Natl Acad Sci USA 95: 12602-12607, 1998.
165. Solomon V, Lecker SH, Goldberg AL. The N-end rule pathway catalyzes a major fraction of the protein degradation in skeletal muscle. J Biol Chem 273: 25216-25222, 1998.
166. Spencer JA, Eliazer S, Ilaria RL Jr, Richardson JA, Olson EN. Regulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger protein. J Cell Biol 150: 771-784, 2000.
167. Stevenson EJ, Giresi P., Koncarevic A, Kandarian SC. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 551: 33-48, 2003.
168. Stitt TN, Drujan D, Clarke BA, P.naro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/P.3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
169. Tang H, Lee M, Khuong A, Wright E, Shrager JB. Diaphragm muscle atrophy in the mouse after long-term mechanical ventilation. Muscle Nerve 48: 272-278, 2013.
170. Testelmans D, Crul T, Maes K, Agten A, Crombach M, Decramer M, Gayan-Ramirez G. Atrophy and hypertrophy signalling in the diaphragm of patients with COP.. Eur Respir J 35: 549-556, 2010.
171. Tintignac LA, Lagirand J, Batonnet S, Sirri V, Leibovitch MP. Leibovitch SA. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem 280: 2847-2856, 2005.
172. Urso ML, Chen YW, Scrimgeour AG, Lee P., Lee KF, Clarkson P.. Alterations in mRNA expression and protein products following spinal cord injury in humans. J Physiol 579: 877-892, 2007.
173. Urso ML, Scrimgeour AG, Chen YW, Thompson P., Clarkson P.. Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components. J Appl Physiol 101: 1136-1148, 2006.
174. Van Gammeren D, Damrauer JS, Jackman RW, Kandarian SC. The I B kinases IKK and IKK are necessary and sufficient for skeletal muscle atrophy. FASEB J 23: 362-370, 2009.
175. Vary TC, Frost RA, Lang CH. Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 294: R1777-R1789, 2008.
176. Wada S, Kato Y, Okutsu M, Miyaki S, Suzuki K, Yan Z, Schiaffino S, Asahara H, Ushida T, Akimoto T. Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy. J Biol Chem 286: 38456-38465, 2011.
177. Waddell DS, Baehr LM, van den Brandt J, Johnsen SA, Reichardt HM, Furlow JD, Bodine SC. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am J Physiol Endocrinol Metab 295: E785-E797, 2008.
178. Wang X, Blagden C, Fan J, Nowak SJ, Taniuchi I, Littman DR, Burden SJ. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev 19: 1715-1722, 2005.
179. Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147: 4160-4168, 2006.
180. Watson ML, Baehr LM, Reichardt HM, Tuckermann JP. Bodine SC, Furlow JD. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. Am J Physiol Endocrinol Metab 302: E1210-E1220, 2012.
181. Willis MS, Bevilacqua A, P.linilkunnil T, Kienesberger P. Tannu M, P.tterson C. The role of ubiquitin ligases in cardiac disease. J Mol Cell Cardiol 71: 43-53, 2014.
182. Willis MS, Ike C, Li L, Wang DZ, Glass DJ, P.tterson C. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res 100: 456-459, 2007.
183. Wing SS, Goldberg AL. Glucocorticoids activate the ATP.ubiquitindependent proteolytic system in skeletal muscle during fasting. Am J Physiol Endocrinol Metab 264: E668-E676, 1993.
184. Witt SH, Granzier H, Witt CC, Labeit S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol 350: 713-722, 2005.
185. Wray CJ, Mammen JM, Hershko DD, Hasselgren P.. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 35: 698-705, 2003.
186. Wu CL, Kandarian SC, Jackman RW. Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3. P.oS One 6: e16171, 2011.
187. Wu Y, Zhao W, Zhao J, Zhang Y, Qin W, P.n J, Bauman WA, Blitzer RD, Cardozo C. REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. Endocrinology 151: 1050-1059, 2010.
188. Yamamoto D, Maki T, Herningtyas EH, Ikeshita N, Shibahara H, Sugiyama Y, Nakanishi S, Iida K, Iguchi G, Takahashi Y, Kaji H, Chihara K, Okimura Y. Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats. Muscle Nerve 41: 819-827, 2010.
189. Yang WL, Wang J, Chan CH, Lee SW, Campos AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG, Lin HK. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325: 1134-1138, 2009.
190. Yang Y, Jemiolo B, Trappe S. P.oteolytic mRNA expression in response to acute resistance exercise in human single skeletal muscle fibers. J Appl Physiol 101: 1442-1450, 2006.
191. Yin HN, Chai JK, Yu YM, Shen CA, Wu YQ, Yao YM, Liu H, Liang LM, Tompkins RG, Sheng ZY. Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats. J Trauma 66: 1083-1090, 2009.
192. Zaglia T, Milan G, Ruhs A, Franzoso M, Bertaggia E, Pianca N, Carpi A, Carullo P. Pesce P. Sacerdoti D, Sarais C, Catalucci D, Krüger M, Mongillo M, Sandri M. Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy. J Clin Invest 124: 2410-2424, 2014.
193. Zeman RJ, Zhao J, Zhang Y, Zhao W, Wen X, Wu Y, P.n J, Bauman WA, Cardozo C. Differential skeletal muscle gene expression after upper or lower motor neuron transection. P.lugers Arch 458: 525-535, 2009.
194. Zhang G, Jin B, Li YP. C/EBP.eta mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO J 30: 4323-4335, 2011.
195. Zhang G, Li YP. p38 MAP. upregulates atrogin1/MAFbx by specific phosphorylation of C/EBP. Skelet Muscle 2: 20, 2012.
196. Zhao W, P.n J, Zhao Z, Wu Y, Bauman WA, Cardozo CP. Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation. J Steroid Biochem Mol Biol 110: 125-129, 2008.
197. Zhu E, Sassoon CSH, Nelson R, P.am HT, Zhu L, Baker MJ, Caiozzo VJ. Early effects of mechanical ventilation on isotonic contractile properties and MAF-box gene expression in the diaphragm. J Appl Physiol 99: 747-756, 2005.